Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Community Pharmacy Services | 5 | 2022 | 22 | 2.830 |
Why?
|
| Pharmaceutical Services | 5 | 2023 | 40 | 1.690 |
Why?
|
| Pharmacists | 8 | 2022 | 69 | 1.510 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2024 | 279 | 1.430 |
Why?
|
| Pharmacy | 4 | 2023 | 34 | 1.230 |
Why?
|
| Pharmacies | 2 | 2022 | 19 | 1.020 |
Why?
|
| Hearing Loss | 1 | 2024 | 37 | 0.900 |
Why?
|
| Diabetes Mellitus | 4 | 2024 | 207 | 0.760 |
Why?
|
| Influenza, Human | 1 | 2021 | 84 | 0.690 |
Why?
|
| Thyroid Diseases | 1 | 2019 | 8 | 0.690 |
Why?
|
| Colchicine | 1 | 2019 | 15 | 0.690 |
Why?
|
| Referral and Consultation | 2 | 2024 | 87 | 0.690 |
Why?
|
| Pericarditis | 1 | 2019 | 14 | 0.680 |
Why?
|
| Cystic Fibrosis | 3 | 2018 | 32 | 0.670 |
Why?
|
| Education, Pharmacy | 4 | 2024 | 104 | 0.670 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 72 | 0.660 |
Why?
|
| Aspirin | 1 | 2019 | 119 | 0.630 |
Why?
|
| Migraine Disorders | 2 | 2015 | 21 | 0.600 |
Why?
|
| Antimicrobial Stewardship | 1 | 2017 | 5 | 0.580 |
Why?
|
| Drug Prescriptions | 1 | 2017 | 43 | 0.570 |
Why?
|
| Health Literacy | 2 | 2017 | 30 | 0.550 |
Why?
|
| Anti-Bacterial Agents | 3 | 2017 | 496 | 0.550 |
Why?
|
| Guideline Adherence | 1 | 2017 | 91 | 0.540 |
Why?
|
| Pneumonia | 1 | 2017 | 89 | 0.540 |
Why?
|
| Education, Pharmacy, Continuing | 1 | 2014 | 2 | 0.490 |
Why?
|
| Humans | 23 | 2024 | 26789 | 0.440 |
Why?
|
| Vaccination | 3 | 2021 | 167 | 0.440 |
Why?
|
| Program Evaluation | 2 | 2014 | 159 | 0.430 |
Why?
|
| Edema | 1 | 2012 | 18 | 0.400 |
Why?
|
| Hypoglycemic Agents | 1 | 2012 | 105 | 0.370 |
Why?
|
| Insulin | 1 | 2012 | 310 | 0.350 |
Why?
|
| Students, Pharmacy | 2 | 2023 | 74 | 0.340 |
Why?
|
| Obesity | 1 | 2012 | 648 | 0.270 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 908 | 0.260 |
Why?
|
| Patient Education as Topic | 2 | 2018 | 87 | 0.260 |
Why?
|
| Diabetes Complications | 1 | 2024 | 66 | 0.230 |
Why?
|
| Female | 11 | 2024 | 14434 | 0.220 |
Why?
|
| Health Personnel | 1 | 2024 | 91 | 0.220 |
Why?
|
| Mass Screening | 1 | 2024 | 141 | 0.220 |
Why?
|
| Middle Aged | 6 | 2024 | 6803 | 0.210 |
Why?
|
| Oklahoma | 2 | 2024 | 970 | 0.210 |
Why?
|
| Outpatients | 1 | 2022 | 42 | 0.210 |
Why?
|
| Adult | 6 | 2024 | 7365 | 0.210 |
Why?
|
| Data Collection | 2 | 2012 | 101 | 0.200 |
Why?
|
| Male | 9 | 2024 | 12854 | 0.190 |
Why?
|
| Immunization Programs | 1 | 2021 | 12 | 0.190 |
Why?
|
| Aged | 3 | 2024 | 5155 | 0.190 |
Why?
|
| Seasons | 1 | 2021 | 82 | 0.180 |
Why?
|
| Surveys and Questionnaires | 4 | 2018 | 916 | 0.170 |
Why?
|
| Hypothyroidism | 1 | 2019 | 11 | 0.170 |
Why?
|
| Hyperthyroidism | 1 | 2019 | 10 | 0.170 |
Why?
|
| Patient Discharge | 2 | 2021 | 96 | 0.170 |
Why?
|
| Drug Interactions | 1 | 2019 | 77 | 0.170 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2019 | 74 | 0.170 |
Why?
|
| Models, Educational | 1 | 2018 | 20 | 0.160 |
Why?
|
| Self Care | 2 | 2015 | 38 | 0.150 |
Why?
|
| Community-Acquired Infections | 1 | 2017 | 29 | 0.140 |
Why?
|
| Patient Medication Knowledge | 1 | 2017 | 1 | 0.140 |
Why?
|
| Hepatitis B Vaccines | 1 | 2017 | 3 | 0.140 |
Why?
|
| Azithromycin | 1 | 2017 | 10 | 0.140 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2016 | 16 | 0.140 |
Why?
|
| Caregivers | 1 | 2018 | 110 | 0.140 |
Why?
|
| Retrospective Studies | 3 | 2017 | 2425 | 0.130 |
Why?
|
| Pilot Projects | 1 | 2017 | 387 | 0.130 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2017 | 84 | 0.130 |
Why?
|
| Continuity of Patient Care | 1 | 2015 | 20 | 0.130 |
Why?
|
| Glycated Hemoglobin A | 2 | 2014 | 64 | 0.130 |
Why?
|
| Medication Reconciliation | 1 | 2015 | 16 | 0.130 |
Why?
|
| Adolescent | 4 | 2018 | 2951 | 0.120 |
Why?
|
| Self-Assessment | 1 | 2014 | 10 | 0.120 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2014 | 2 | 0.120 |
Why?
|
| School Health Services | 1 | 2014 | 34 | 0.120 |
Why?
|
| Prediabetic State | 1 | 2014 | 10 | 0.120 |
Why?
|
| Triazoles | 1 | 2014 | 14 | 0.120 |
Why?
|
| Pyrazines | 1 | 2014 | 23 | 0.120 |
Why?
|
| Patient Satisfaction | 1 | 2014 | 89 | 0.120 |
Why?
|
| Schools, Pharmacy | 2 | 2024 | 22 | 0.110 |
Why?
|
| Educational Measurement | 1 | 2014 | 111 | 0.110 |
Why?
|
| Asthma | 1 | 2014 | 57 | 0.110 |
Why?
|
| Advisory Committees | 2 | 2024 | 31 | 0.110 |
Why?
|
| Diet | 1 | 2015 | 223 | 0.110 |
Why?
|
| United States | 3 | 2024 | 2029 | 0.110 |
Why?
|
| Patients | 1 | 2012 | 17 | 0.110 |
Why?
|
| Young Adult | 3 | 2017 | 2576 | 0.100 |
Why?
|
| Professional Role | 1 | 2012 | 42 | 0.100 |
Why?
|
| Linear Models | 1 | 2012 | 201 | 0.100 |
Why?
|
| Overweight | 1 | 2012 | 110 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 322 | 0.090 |
Why?
|
| Curriculum | 2 | 2023 | 258 | 0.080 |
Why?
|
| Child | 3 | 2021 | 2141 | 0.070 |
Why?
|
| Ambulatory Care Facilities | 2 | 2018 | 51 | 0.070 |
Why?
|
| Societies, Pharmaceutical | 1 | 2024 | 3 | 0.060 |
Why?
|
| Focus Groups | 1 | 2024 | 89 | 0.060 |
Why?
|
| Hospitals, Teaching | 1 | 2021 | 25 | 0.050 |
Why?
|
| Leadership | 1 | 2020 | 49 | 0.040 |
Why?
|
| Entrepreneurship | 1 | 2018 | 2 | 0.040 |
Why?
|
| Models, Psychological | 1 | 2018 | 80 | 0.040 |
Why?
|
| Personal Satisfaction | 1 | 2018 | 27 | 0.040 |
Why?
|
| Influenza Vaccines | 1 | 2018 | 48 | 0.040 |
Why?
|
| Commerce | 1 | 2018 | 47 | 0.040 |
Why?
|
| Hepatitis B | 1 | 2017 | 12 | 0.040 |
Why?
|
| Solutions | 1 | 2016 | 31 | 0.040 |
Why?
|
| Drug Monitoring | 1 | 2017 | 34 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 139 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 400 | 0.030 |
Why?
|
| Motivation | 1 | 2018 | 207 | 0.030 |
Why?
|
| Documentation | 1 | 2015 | 24 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2017 | 391 | 0.030 |
Why?
|
| Complementary Therapies | 1 | 2015 | 14 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2016 | 160 | 0.030 |
Why?
|
| Counseling | 1 | 2015 | 51 | 0.030 |
Why?
|
| Central Nervous System Stimulants | 1 | 2015 | 30 | 0.030 |
Why?
|
| Caffeine | 1 | 2015 | 38 | 0.030 |
Why?
|
| Infant | 1 | 2018 | 954 | 0.030 |
Why?
|
| Sitagliptin Phosphate | 1 | 2014 | 1 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 241 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2017 | 224 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2016 | 1214 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 1924 | 0.020 |
Why?
|